In summary, our study demonstrates that YTHDF2, through O-GlcNAc modification, influences the stability of CCNE1 mRNA and cell cycle regulation, providing novel therapeutic strategies for IDD. This evidence concerns the gene CCNE1 and intervertebral disk degenerative disorder.